您的位置: 首页 > 农业专利 > 详情页

polypeptide fragment, isolated polynucleotide, recombinant vector, recombinant host cell, method for identifying compounds, compound, antibody, and use of a compound, pharmaceutical composition, or antibody
专利权人:
European Molecular Biology Laboratory (EMBL)
发明人:
Chloe Zubieta,Eva Kowalinski,Stephen Cusack
申请号:
BR112012023166
公开号:
BR112012023166A2
申请日:
2011.03.15
申请国别(地区):
BR
年份:
2020
代理人:
摘要:
polypeptide fragment, isolated polynucleotide, recombinant vector, recombinant host cell, methods for identifying compounds and for producing compounds, antibody and use thereof the present invention relates to polypeptide fragments comprising an amino terminal fragment of the pa subunit of an rna viral RNA-dependent polymerase, which has endonuclease activity, in which said pa subunit is from the influenza to pandemic virus h1n1 2009 or is a variant thereof. this invention also relates to (i) crystals of the polypeptide fragments that are suitable for determining the structure of said polypeptide fragments using x-ray crystallography, and (ii) computational methods that use the structural coordinates of said polypeptide to selecting and determining compounds that modulate, preferably inhibit, the endonucleolytically active site in the polypeptide fragment. moreover, this invention relates to methods for identifying compounds that bind to polypeptide fragments pa, which have endonuclease activity, and preferably inhibit said endonucleolytic activity, preferably in an environment of high productivity. this invention also relates to compounds that are capable of modulating, preferably inhibiting, the endonuclease activity of the polypeptide fragment of the pa subunit, or variant thereof, of the present invention, and pharmaceutical compositions comprising said compounds for the treatment of conditions of disease caused by viral infections by the virus of the family orthomyxoviridae, family bunyaviridae and / or family arenviridae, preferably caused by viral infections by the pandemic influenza virus h1n1 2009. preferably, said compounds are identified by the methods disclosed herein, or said pharmaceutical compositions are produced by the methods disclosed here.fragmento de polipeptídeo, polinucleotídeo isolado, vetor recombinante, célula hospedeira recombinante, métodos para identificar compostos e para produzir compostos, anticorpo e uso do mesmo a presente invenção
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充